Evidence map›Paper›PMID 40563242›Full record

ArticleBioinformatics (Oxford, England)2025

Topolow: a mapping algorithm for antigenic cross-reactivity and binding affinity assays.

Omid Arhami, Pejman Rohani

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Omid ArhamiInstitute of Bioinformatics, University of Georgia, Athens, GA 30602-7229, United States.ORCID 0009-0005-2681-6598
Pejman RohaniInstitute of Bioinformatics, University of Georgia, Athens, GA 30602-7229, United States.ORCID 0000-0002-7221-3801

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00018 · NIAID · UNIVERSITY OF GEORGIA · PI TOMPKINS, S. MARK · 2021 to 2025
$21.6M
NIAID Centers of Excellence for Influenza Research and Response, CEIRRNIAID NIH HHS 75N93021C00018
6 · The paper itself

Abstract

motivationUnderstanding antigenic evolution through cross-reactivity assays is crucial for tracking rapidly evolving pathogens requiring regular vaccine updates. However, existing cartography methods, commonly based on multidimensional scaling (MDS), face significant challenges with sparse and complex data, producing incomplete and inconsistent maps. There is an urgent need for robust computational methods that can accurately map antigenic relationships from incomplete experimental data while maintaining biological relevance, especially given that more than 95% of possible measurements could be missing in large-scale studies.

resultsWe present Topolow, an algorithm that transforms cross-reactivity and binding affinity measurements into accurate positions in a phenotype space. Using a physics-inspired model, Topolow achieved comparable prediction accuracy to MDS for H3N2 influenza and 56% and 41% improved accuracy for dengue and HIV, while maintaining complete positioning of all antigens. The method effectively reduces experimental noise and bias, determines optimal dimensionality through likelihood-based estimation, avoiding distortions due to insufficient dimensions, and demonstrates orders of magnitude better stability across multiple runs. We also introduce antigenic velocity vectors, which measure the rate of antigenic advancement of each isolate per unit of time against its temporal and evolutionary related background, revealing the underlying antigenic relationships and cluster transitions. AVAILABILITY AND IMPLEMENTATION: Topolow is implemented in R and freely available at https://doi.org/10.5281/zenodo.15620983 and https://github.com/omid-arhami/topolow.

Indexed as

AlgorithmsAntigensAntigens, ViralComputational BiologyCross ReactionsDengue VirusHIVHumansInfluenza A Virus, H3N2 SubtypeAntigensAntigens, Viral

Identifiers

PMID40563242
PMCPMC12237505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.